NL-OMON56843
Not yet recruiting
Not Applicable
Cerebrospinal fluid concentrations of polyols following traumatic brain injury - SUGAR-TBI
Amsterdam UMC0 sites30 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- neurotrauma
- Sponsor
- Amsterdam UMC
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult (aged at least 18 years)
- •Clinical diagnosis of moderate to severe TBI, classified by Glasgow Coma
- •Scale (GCS), with GCS \<9 indicating severe TBI and GCS 9\-12 moderate TBI
- •Extra ventricular drain in situ
Exclusion Criteria
- •Admission to the ICU is solely for the purposes of palliative care or
- •confirmation of organ donation
- •Advanced care directive or previously stated wish not to be included in
- •research activities
- •Past medical history of diabetes mellitus
- •HbA1c \>\= 6\.5%
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastasescentral nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinibJPRN-UMIN000004703Osaka City University10
Completed
Phase 4
Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol following intravenous and oral administratioACTRN12615000322538Royal Melbourne Hospital21
Not yet recruiting
Not Applicable
Cerebrospinal fluid metabolites as marker for the severity of progressive post-hemorrhagic ventricular dilatation in preterm infantsNL-OMON30135niversitair Medisch Centrum Sint Radboud125
Active, not recruiting
Not Applicable
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics
Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System DiseasesISRCTN34007592Trinity Translational Medicine Institute12